ILROG emergency guidelines for radiation therapy of hematological malignancies during the COVID-19 pandemic
Year: 2020
Type: article
Abstract: The International Lymphoma Radiation Oncology Group (ILROG) guidelines for using radiation therapy (RT) in hematological malignancies are widely used in many countries. The emergency situation created by the COVID-19 pandemic may result in limitations of treatment resources. Furthermore, in recognition of the need to also reduce the exposure of patients and staff to potential infection with COVID-19, the ILROG task force has made recommendations for alternative radiation treatment schemes. The emphasis is on maintaining clinical efficacy and safety by increasing the dose per fraction while reducing the number of daily treatments. The guidance is informed by adhering to acceptable radiobiological parameters and clinical tolerability. The options for delaying or omitting RT in some hematological categories are also discussed.
Source: Blood
Institutions: Memorial Sloan Kettering Cancer Center, The University of Texas MD Anderson Cancer Center, University of Turin, Dana-Farber Cancer Institute, St Thomas' Hospital, Guy's and St Thomas' NHS Foundation Trust, University of Copenhagen, Rigshospitalet, National Health Service, University of Manchester, National Institute for Health and Care Research, NIHR Manchester Biomedical Research Centre, Chinese Academy of Medical Sciences & Peking Union Medical College, Cancer Hospital of Chinese Academy of Medical Sciences, Peter MacCallum Cancer Centre
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
OpenAlex ID: W3015535093